PortfoliosLab logoPortfoliosLab logo
AMZN vs. MRNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMZN vs. MRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amazon.com, Inc (AMZN) and Moderna, Inc. (MRNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMZN achieves a 9.95% return, which is significantly lower than MRNA's 74.94% return.


AMZN

1D
1.51%
1M
-7.22%
YTD
9.95%
6M
10.77%
1Y
22.47%
3Y*
26.52%
5Y*
9.62%
10Y*
21.45%

MRNA

1D
5.16%
1M
10.45%
YTD
74.94%
6M
102.39%
1Y
89.18%
3Y*
-26.31%
5Y*
-24.19%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMZN vs. MRNA - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
AMZN
Amazon.com, Inc
9.95%5.21%44.39%80.88%-49.62%2.38%76.26%23.03%-7.81%
MRNA
Moderna, Inc.
74.94%-29.08%-58.19%-44.63%-29.28%143.11%434.10%28.09%-17.90%

Correlation

The correlation between AMZN and MRNA is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Dec 10, 2018

0.20

The correlation between AMZN and MRNA shifts across timeframes, from 0.13 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AMZN:

$2.76T

MRNA:

$20.38B

EPS

AMZN:

$8.37

MRNA:

-$8.16

PS Ratio

AMZN:

3.71

MRNA:

9.07

PB Ratio

AMZN:

6.24

MRNA:

2.75

Total Revenue (TTM)

AMZN:

$742.78B

MRNA:

$2.23B

Gross Profit (TTM)

AMZN:

$348.59B

MRNA:

-$309.00M

EBITDA (TTM)

AMZN:

$152.71B

MRNA:

-$3.02B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMZN vs. MRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMZN
AMZN Risk / Return Rank: 6262
Overall Rank
AMZN Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
AMZN Sortino Ratio Rank: 6060
Sortino Ratio Rank
AMZN Omega Ratio Rank: 5858
Omega Ratio Rank
AMZN Calmar Ratio Rank: 6363
Calmar Ratio Rank
AMZN Martin Ratio Rank: 6464
Martin Ratio Rank

MRNA
MRNA Risk / Return Rank: 7878
Overall Rank
MRNA Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
MRNA Sortino Ratio Rank: 7979
Sortino Ratio Rank
MRNA Omega Ratio Rank: 7474
Omega Ratio Rank
MRNA Calmar Ratio Rank: 7979
Calmar Ratio Rank
MRNA Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMZN vs. MRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amazon.com, Inc (AMZN) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AMZNMRNADifference
Sharpe ratioReturn per unit of total volatility

-0.65

Sortino ratioReturn per unit of downside risk

-1.03

Omega ratioGain probability vs. loss probability

1.15

1.25

-0.10

Calmar ratioReturn relative to maximum drawdown

1.04

2.53

-1.49

Martin ratioReturn relative to average drawdown

2.49

5.00

-2.50

AMZN vs. MRNA - Sharpe Ratio Comparison

The current AMZN Sharpe Ratio is 0.75, which is lower than the MRNA Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of AMZN and MRNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AMZNMRNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.75

1.40

-0.65

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

-0.37

+0.64

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.66

Sharpe Ratio (All Time)

Calculated using the full available price history

0.57

0.20

+0.36

Drawdowns

AMZN vs. MRNA - Drawdown Comparison

The maximum AMZN drawdown since its inception was -94.40%, roughly equal to the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for AMZN and MRNA.


Loading charts...

Drawdown Indicators


AMZNMRNADifference

Max Drawdown

Largest peak-to-trough decline

-94.40%

-95.38%

+0.98%

Max Drawdown (1Y)

Largest decline over 1 year

-21.74%

-35.51%

+13.77%

Max Drawdown (3Y)

Largest decline over 3 years

-30.88%

-86.58%

+55.70%

Max Drawdown (5Y)

Largest decline over 5 years

-56.15%

-95.38%

+39.23%

Max Drawdown (10Y)

Largest decline over 10 years

-56.15%

Current Drawdown

Current decline from peak

-7.71%

-89.35%

+81.64%

Average Drawdown

Average peak-to-trough decline

-28.12%

-56.66%

+28.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.03%

17.90%

-8.87%

Volatility

AMZN vs. MRNA - Volatility Comparison

The current volatility for Amazon.com, Inc (AMZN) is 7.43%, while Moderna, Inc. (MRNA) has a volatility of 18.65%. This indicates that AMZN experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMZNMRNADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.43%

18.65%

-11.22%

Volatility (6M)

Calculated over the trailing 6-month period

20.40%

48.15%

-27.75%

Volatility (1Y)

Calculated over the trailing 1-year period

30.03%

64.07%

-34.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.51%

66.39%

-30.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.46%

71.92%

-39.46%

Dividends

AMZN vs. MRNA - Dividend Comparison

Neither AMZN nor MRNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AMZN vs. MRNA - Financials Comparison

This section allows you to compare key financial metrics between Amazon.com, Inc and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B20222023202420252026
181.52B
389.00M
(AMZN) Total Revenue
(MRNA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AMZN and MRNA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRNA has higher volatility (18.65%) compared to AMZN (7.43%). In terms of maximum drawdown, AMZN dropped -94.40% vs MRNA's -95.38%.

MRNA currently has the higher Sharpe Ratio (1.40 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMZN and MRNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer